Table 2.

Clinical features of Mullerian adenosarcoma

Case	Age (years)	Menopause	Macroscopic findings	Surgery	Adjuvant therapy	PFS (month)	Site of recurrence	OS (month)	Status at last follow
Recurrent case
1	50	Menopause	polypoid	mRH + BSO	IEP	6	Retroperitoneal tissue	7	DOD
2	57	Menopause	polypoid	mRH + BSO + PLA + PALA	–	71	Lung, Bone	73	DOD
3	66	Menopause	polypoid	TAH + BSO + PLA + PALA	–	12	Lung	31	Death of other disease (SAH)
4	65	Menopause	polypoid	TAH + BSO	–	10	Unknown site	10	AWD
Non-recurrent case
5	75	Menopause	polypoid	TAH + BSO	5FU	2		2	NED
6	58	Menopause	polypoid	mRH + BSO + PLA + PALA	5FU	110		110	NED
7	43	–	polypoid	TAH + BSO + PLA	IAP	114		114	NED

BSO bilateral salpingo-oophrectomy, DOD death of disease, IAP: Ifosfamide and doxorubicin and cisplatin, IEP ifosfamide and epirubicin and cisplatin,

5-FU 5-furuolouracil, mRH modified radical hysterectomy, NED no evidence of disease, PALA paraaortic lymphadnectomy, PLA pelvic lymphadnectomy,

SAH subarachnoid hemorrhage